UPDATE: Testosterone Replacement Therapy (TRT) Litigation

(1) NPR Discusses Testosterone & Potential Adverse Health Effects NPR recently discussed the popularity of testosterone replacement therapies, and how the The Food and Drug Administration is reassessing the safety of testosterone products. A spokesperson reiterated the agency’s own guidelines: None of the products approved by the FDA should be prescribed unless low testosterone is associated with a medical condition. …

“Low T” Case Filed in California Against Auxilium’s Testim Drug

A 58-year-old California man who suffered injuries after using the testosterone replacement therapy (“TRT”) drug Testim has sued manufacturer Auxilium Pharmaceuticals Inc., claiming it coordinated a massive ad campaign to aggressively promote the need for its product while failing to warn users of life-threatening side effects. In a Feb. 26 lawsuit filed in U.S. District Court for the Central District …

‘Low T’ Drug Cases Involving Abbott’s Androgel Could Be Next MDL, Mass Tort

  Several products liability attorneys say that the recent appearance of lawsuits nationwide against the manufacturers of testosterone therapy drugs indicates the potential for multidistrict litigation and possibly a new mass tort. Many of the current suits filed in federal courts across the country are against Abbott Laboratories—maker of the topical testosterone therapy drug AndroGel and the anti-seizure medication Depakote.  …